L&K Biomed Co., Ltd. logo

L&K Biomed Co., Ltd. (156100)

Market Open
11 Aug, 03:18
KRX SM KRX SM
3,995. 00
+45
+1.1392%
219.3B Market Cap
- P/E Ratio
- Div Yield
85,413 Volume
- Eps
3,950
Previous Close
Add Transaction
Day Range
3,750 4,080
Year Range
2,730 16,400
Want to track 156100 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

156100 trading today higher at ₩3,995, an increase of 1.1392% from yesterday's close, completing a monthly decrease of -15.3602% or -₩725. Over the past 12 months, 156100 stock lost -69.031%.
156100 is not paying dividends to its shareholders.
The last earnings report, released on Mar 12, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
L&K Biomed Co., Ltd. has completed 1 stock splits, with the recent split occurring on Oct 06, 2014.
The company's stock is traded on one exchange.

156100 Chart

People also search for

Samsung Biologics Co., Ltd.
1,588,000
+1.211%
Celltrion Inc.
204,500
+1.7413%
ALTEOGEN Inc.
340,500
-2.1552%
Sk Biopharmaceuticals Co., Ltd.
90,600
+2.1421%
ABL Bio Inc.
92,300
-1.3889%

L&K Biomed Co., Ltd. (156100) FAQ

What is the stock price today?

The current price is ₩3,995.00.

On which exchange is it traded?

L&K Biomed Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 156100.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 219.3B.

Has L&K Biomed Co., Ltd. ever had a stock split?

L&K Biomed Co., Ltd. had 1 splits and the recent split was on Oct 06, 2014.

L&K Biomed Co., Ltd. Profile

Health Care Technology Industry
Healthcare Sector
Mr. Guk-jin Kang CEO
KRX SM Exchange
- ISIN
KR Country
60 Employees
- Last Dividend
6 Oct 2014 Last Split
- IPO Date

Overview

L&K Biomed Ltd. is a globally recognized medical company that specializes in the manufacturing and distribution of spinal implants. Founded in 2008, the company has its headquarters in Yongin-si, South Korea. L&K Biomed is dedicated to advancing spinal care through innovative solutions, catering to a wide range of spinal conditions with their extensive product line. Their commitment to quality and patient safety has positioned them as a leader in the spinal implant industry, serving customers worldwide.

Products and Services

  • Anterior and Expandable Lateral Lumbar Cage Systems: Designed for use in spinal fusion surgeries, these cage systems help to stabilize and support the spine post-surgery, promoting the fusion of the vertebral bones.
  • Cervical Interbody Fusion Cage: This device is intended for cervical spinal fusion procedures, aiding in the alignment and stabilization of the cervical spine.
  • Anterior Cervical Plate System: Used in conjunction with interbody cages, this system provides additional stability to the cervical spine through a plate fixed to the front of the vertebrae.
  • Posterior Cervical Fixation System: Designed for the posterior approach to cervical spine surgery, this system offers stabilization and support to the cervical spine from the back.
  • Spinal Fixation Screw, Lumber Plate, and Spinal Fixation Systems: These components are used in various spinal surgeries to provide stabilization and support to the spine, ensuring proper alignment and facilitating fusion.
  • Posterior Lumbar Interbody Cage: Specifically designed for the lumbar region of the spine, this cage is used in spinal fusion surgeries to promote the proper healing and fusion of the vertebrae.
  • Lateral and Anterior Lumbar Interbody Cage, and Transforaminal Lumbar Interbody Cage: These cages are designed for insertion in different approaches to lumbar spine surgery, tailored to the specific needs of the procedure and patient anatomy.
  • MIS Spinal and Spinal Fixation Systems: Minimally Invasive Surgery (MIS) systems are designed to reduce recovery time and surgical impact on the patient while providing optimal stabilization and support to the spine.
  • SI Joint Fusion System: This system is designed for the surgical treatment of sacroiliac joint dysfunction, offering a minimally invasive option for stabilizing and fusing the SI joint.

Contact Information

Address: 16-25, Dongbaekjungang-ro 16beon-gil
Phone: 82 2 1600 0841